Formulation Development

  • Formulation pipeline has 250+ complex products where >75% is development for International markets majorly in Respiratory, Oncology, ARVs, Ophthalmology, CNS, CVS etc.
  • Cipla’s development lab is equipped with state-of-the-art infrastructure for development of innovative technology products.
  • Cipla develops and applies skills to ensure the quality of its products right from the design to the manufacturing stage safeguarding patients’ safety and efficacy of the products.
  • The development process for the products followed, ensures formulation development based on Quality by Design (QBD) principles enabling robust, reproducible and regulatory complied products in the market.